Emergent Biosolutions
EBS
EBS
272 hedge funds and large institutions have $2.25B invested in Emergent Biosolutions in 2019 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 104 increasing their positions, 91 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less call options, than puts
Call options by funds: $1.71M | Put options by funds: $1.92M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
40% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 58
Holders
272
Holding in Top 10
3
Calls
$1.71M
Puts
$1.92M
Top Buyers
| 1 | +$31.2M | |
| 2 | +$26.6M | |
| 3 | +$22.6M | |
| 4 |
Renaissance Technologies
New York
|
+$19.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.5M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$12.5M | |
| 3 | -$10.8M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$8.43M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.46M |